PHASE-II STUDY OF CARBOPLATIN AND CYTOSINE-ARABINOSIDE IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA

被引：5
|
作者：
MULDER, NH [1 ]
SLEIJFER, DT [1 ]
DEVRIES, EGE [1 ]
KOOPS, HS [1 ]
WILLEMSE, PHB [1 ]
机构：
[1] STATE UNIV GRONINGEN HOSP,DEPT SURG ONCOL,9713 EZ GRONINGEN,NETHERLANDS
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1990年 / 116卷 / 03期
关键词：
Chemotherapy; Malignant melanoma;
D O I：
10.1007/BF01612907
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment. © 1990 Springer-Verlag.
引用
收藏
页码：301 / 302
页数：2
相关论文
共 50 条
  • [21] PHASE-II STUDY OF DIBROMODULCITOL IN ADVANCED MALIGNANT-MELANOMA
    MURRAY, N
    SILVER, H
    SHAH, A
    WILSON, K
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 172 - 172
  • [22] PHASE-II STUDY OF MITOLACTOL IN ADVANCED MALIGNANT-MELANOMA
    MURRAY, N
    SILVER, H
    SHAH, A
    WILSON, K
    CANCER TREATMENT REPORTS, 1985, 69 (06): : 723 - 724
  • [23] PHASE-II STUDY OF VINDESINE IN METASTATIC MALIGNANT-MELANOMA
    ARSENEAU, JC
    MELLETTE, SJ
    KUPERMINC, M
    WOLTER, J
    CANCER TREATMENT REPORTS, 1981, 65 (3-4): : 355 - 356
  • [24] PREDNIMUSTINE IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II STUDY
    PEDERSEN, L
    LOBER, J
    DALMARK, M
    MOURIDSEN, HT
    CANCER TREATMENT REPORTS, 1987, 71 (12): : 1315 - 1316
  • [25] PHASE-II STUDY OF EPIRUBICIN IN ADVANCED MALIGNANT-MELANOMA
    LOPEZ, M
    PERNO, CF
    PAPALDO, P
    DILAURO, L
    GANZINA, F
    BARDUAGNI, A
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (03) : 315 - 317
  • [26] COMBINED CARBOPLATIN AND CYTOSINE-ARABINOSIDE IN METASTATIC MELANOMA REFRACTORY TO DACARBAZINE
    BAJETTA, E
    BUZZONI, R
    VICARIO, G
    TUMORI, 1995, 81 (04) : 238 - 240
  • [27] PHASE-II STUDY OF BISANTRENE IN ADVANCED MALIGNANT-MELANOMA
    PAPADOPOULOS, NEJ
    TENNEY, DM
    CHAWLA, S
    PLAGER, C
    BENJAMIN, RS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 174 - 174
  • [28] PHASE-II STUDY WITH IFOSFAMIDE IN ADVANCED MALIGNANT-MELANOMA
    NEGRETTI, E
    FERRARI, L
    BONFANTE, V
    BAJETTA, E
    TUMORI, 1988, 74 (02) : 163 - 165
  • [29] PHASE-II EVALUATION OF ORAL IDARUBICIN (4-DEMETHOXYDAUNORUBICIN) IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA
    LOPEZ, M
    DILAURO, L
    PAPALDO, P
    GANZINA, F
    DIPIETRO, N
    LAZZARO, B
    CANCER TREATMENT REPORTS, 1986, 70 (07): : 911 - 912
  • [30] PHASE-II TRIALS OF RECOMBINANT LEUKOCYTE A INTERFERON IN DISSEMINATED MALIGNANT-MELANOMA - RESULTS IN 96 PATIENTS
    CREAGAN, ET
    AHMANN, DL
    FRYTAK, S
    LONG, HJ
    CHANG, MN
    ITRI, LM
    CANCER TREATMENT REPORTS, 1986, 70 (05): : 619 - 624
12345